News

Gemcitabine is indicated for first-line therapy for ovarian, breast, lung, and pancreatic cancers. Uman is expected to file an abbreviated new drug application (ANDA) for gemcitabine with the

Meridian Medical Technologies, a Pfizer subsidiary, has signed a settlement agreement with Intelliject and Sanofi that will resolve pending patent litigation related to Intelliject’s NDA for its epinephrine

The EMR will provide an easy way to incorporate Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, psychiatric practice guideline-based clinical decision support and patient education material

It is prescribed under the brand name Oxsoralen-Ultra (methoxsalen) Capsules, USP, 10mg. Oxsoralen-Ultra, in combination with a special type of phototherapy called PUVA (Psoralen plus UVA light) therapy,

The agreement expands Evotec’s drug discovery platform into the area of respiratory diseases through IR Pharma’s expertise in in vitro and in vivo Respiratory pharmacology. Under the alliance,

The $20MM facility will serve to expand Asymchem’s capabilities in high volume processing and back-end ingredient and intermediate production. The new facility will accommodate high volume processes and

As per the terms of the agreement, Arno will pay certain research, clinical and regulatory milestone payments as well as royalties on net sales of licensed products to

AFC is contributing to the Rx-360’s joint audit pilot program as the first US-based active pharmaceutical ingredient (API) manufacturer to be audited. AMPAC quality and regulatory affairs vice

The product was initially developed by BioSante and latter licensed to Teva for late stage clinical development, regulatory and marketing activities. BioSante is expected to receive royalties and